Illumina and FlowJo Partner to Develop and Co-Market a Software Solution for Single Cell Genomics

August 11, 2016 Leave a comment 2,826 Views

Software for analysis and reporting of single cell data will advance research into cell function, disease progression, and therapeutic response Illumina, Inc. (NASDAQ: ILMN) and FlowJo, LLC, today announced a partnership to develop and co-market analysis software for single cell ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: disease progression

Illumina and FlowJo Partner to Develop and Co-Market a Software Solution for Single Cell Genomics

Introducing BGI’s Dr. Tom System – An Advanced and Intuitive RNA Data Visualization and Analysis System for Easy and Efficient Research and Discovery

Single-cell RNA sequencing provides a breakthrough for tomorrow’s dentistry

Upcoming Webinar – Explore chronic liver disease gene expression data

Sources of variation in cell-type RNA-Seq profiles

Grant will fund single-cell RNA sequencing study of link between senescence and Parkinson’s disease

A practical application of generative adversarial networks for RNA-seq analysis to predict the molecular progress of Alzheimer’s disease

Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer